Scout Clinical and ICON Findings From Rare Disease Trial Participant Focus Group
Scout Clinical, a provider of comprehensive clinical trial patient services, has announced the results of their rare disease clinical trial patient focus group. Conducted in partnership with ICON plc, the initiative sought to amplify the voices of those whose lives are touched by rare diseases.
The information from these focus groups addresses the gap between the experiences and perceptions of patients and the participation support services provided to them during clinical trials. The series found:
- Rare disease trial participation exposes participants to significant pressures across a variety of categories—including financial, physical, logistical, psychological and emotional—all incremental to the burdens participants already bear by virtue of living with a rare disease.
- Trial participation support services had effectively helped respondents overcome barriers to participation.
- Fully 30% of participants identified emotional support/counseling as a service that could make it easier for them to participate in a clinical trial.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
